Manoj Chelvanambi

Jul 12, 2023 | cell.com | Manoj Chelvanambi |Jennifer Wargo

• None Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. :• None Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. :• None Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. :• None Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Jan 27, 2023 | mdpi.com | Anne T. Knisely |Jennifer Wargo |Manoj Chelvanambi |Yongwoo David Seo

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReviewbyAnne Knisely 1, Yongwoo David Seo 2, Jennifer A. Wargo 2 and Manoj Chelvanambi 2,* 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA2Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA*Author to whom correspondence should be addressed.